SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-056839
Filing Date
2024-03-04
Accepted
2024-03-04 07:14:30
Documents
15
Period of Report
2024-03-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d806380d8k.htm   iXBRL 8-K 29582
2 EX-99.1 d806380dex991.htm EX-99.1 11232
  Complete submission text file 0001193125-24-056839.txt   173622

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sttk-20240301.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sttk-20240301_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sttk-20240301_pre.xml EX-101.PRE 11716
16 EXTRACTED XBRL INSTANCE DOCUMENT d806380d8k_htm.xml XML 3762
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

IRS No.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39593 | Film No.: 24712826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)